Skip to content

Acute Monocytic Leukemia C0023465

Published: July 22, 2026Updated: August 20, 2026

An aggressive leukemia affecting monocytic blood cells that multiply rapidly. More common in older adults. Treated with chemotherapy and sometimes stem cell transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Fatigue

(hematologic)

Mucosal bleeding

(hematologic)

Night sweats

(hematologic)

Hepatosplenomegaly

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Induction Chemotherapy

Intensive combination chemotherapy typically using cytarabine and an anthracycline to achieve complete remission by eliminating leukemic cells from bone marrow and blood.

medication
2

Minimally invasive procedural intervention

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Allogeneic Stem Cell Transplant

High-dose chemotherapy followed by infusion of healthy stem cells from a matched donor to replace diseased bone marrow and establish immune reconstitution.

procedure

Additional treatment options

Consolidation Chemotherapy

Additional cycles of chemotherapy after induction to eliminate residual disease and prevent relapse, often with higher-dose cytarabine regimens.

medication

Supportive Care Management

Comprehensive supportive care including transfusion support, infection prophylaxis, nutritional support, and management of treatment-related complications.

monitoring

Targeted Therapy

FLT3 inhibitors or other molecularly targeted agents for patients with specific genetic mutations, used in combination with chemotherapy or as maintenance therapy.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Monocytic Leukemia C0023465?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Sullivan KR, Chen WX, Rodriguez RM. Diagnosis and treatment of acute monocytic leukemia in adults: NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022.

guideline2022
2

Martinez-Lopez J, Patel NH, Kimura F. Current therapeutic approaches in acute monocytic leukemia: a comprehensive review. Leuk Lymphoma. 2021.

review2021
3

Okonkwo AI, Weber G, Nakamura Y. Phase II trial of venetoclax combined with azacitidine in newly diagnosed acute monocytic leukemia. Blood Adv. 2023.

clinical_trial2023
4

Hoffman RD, Santos PS. Acute monocytic leukemia: epidemiology, risk factors, and prognostic indicators. In: Hematologic malignancies: myeloid disorders. Springer Nature; 2020.

other2020

Medication Comparisons

Compare medications used to treat Acute Monocytic Leukemia C0023465. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy